Anavex Life Sciences (AVXL) Shareholder's Equity (QoQ) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.47% |
| Sep 30, 2025 | 4.30% |
| Jun 30, 2025 | -8.82% |
| Mar 31, 2025 | -10.06% |
| Dec 31, 2024 | -7.77% |
| Sep 30, 2024 | -7.33% |
| Jun 30, 2024 | -3.84% |
| Mar 31, 2024 | -0.46% |
| Dec 31, 2023 | -4.43% |
| Sep 30, 2023 | -3.34% |
| Jun 30, 2023 | 1.10% |
| Mar 31, 2023 | 7.43% |
| Dec 31, 2022 | -5.17% |
| Sep 30, 2022 | -5.47% |
| Jun 30, 2022 | -0.96% |
| Mar 31, 2022 | 3.99% |
| Dec 31, 2021 | -2.95% |
| Sep 30, 2021 | -4.03% |
| Jun 30, 2021 | 107.29% |
| Mar 31, 2021 | 63.73% |
| Dec 31, 2020 | 69.99% |
| Sep 30, 2020 | 10.36% |
| Jun 30, 2020 | -0.45% |
| Mar 31, 2020 | -4.50% |
| Dec 31, 2019 | 27.95% |
| Sep 30, 2019 | -4.24% |
| Jun 30, 2019 | 23.31% |
| Mar 31, 2019 | -11.71% |
| Dec 31, 2018 | -12.80% |
| Sep 30, 2018 | -5.36% |
| Jun 30, 2018 | 4.92% |
| Mar 31, 2018 | -12.00% |
| Dec 31, 2017 | -1.31% |
| Sep 30, 2017 | 10.37% |
| Sep 30, 2015 | 94.98% |
| Jun 30, 2015 | 39.71% |
| Mar 31, 2015 | 893.88% |
| Dec 31, 2014 | 145.62% |
| Sep 30, 2014 | -97.40% |
| Jun 30, 2014 | -11.89% |
| Mar 31, 2014 | 603.41% |
| Dec 31, 2013 | 32.19% |
| Sep 30, 2013 | 30.68% |
| Jun 30, 2013 | -3.45% |
| Mar 31, 2013 | -3.19% |
| Dec 31, 2012 | -15.77% |
| Sep 30, 2012 | -30.82% |
| Jun 30, 2012 | 24.95% |